In summary, the conclusion is that in the NAC-resistant group, the numerous mast cells, due to the lack of BTG2, are induced by IL-33 secreted by endothelial cells to produce more IL-2, thereby promoting the differentiation of Tregs, ultimately leading to suppression of anti-tumor immunity in the tumor microenvironment. The gene discussed is BTG2; the disease is neoplasm.